divislab glp-1 novo nordisk A $60 billion industry just found its next growth lever. 💊 With the expiry of a key patent on March 20, 2026, Indian pharma majors are launching generic weight-loss and diabetes drugs Novo Nordisk cuts prices as

Use it daily and see the magic happening

Petersburg, Laredo,Madison, Chandler, Buffalo, Lubbock, Scottsdale, Reno, Glendale, Gilbert[q], WinstonSalem, North Las Vegas, Norfolk[m], Chesapeake[m], Garland, Irving, Hialeah, Fremont, Boise[r], Richmond[m], Baton Rouge[s], Spokane, Des Moines, Tacoma, San Bernardino, Modesto, Fontana, Santa Clarita, Birmingham, Oxnard, Fayetteville, Moreno Valley, Rochester, Glendale, Huntington Beach, Salt Lake City, Grand Rapids, Amarillo, Yonkers, Aurora, Montgomery, Akron, Little Rock, Huntsville, Augusta[t], Port St

Option five: document everything

Retatrutide achieved up to 24.2% mean weight loss after 48 weeks in individuals with obesity and 16.9% in those with T2D after 36 weeks

(2016) 311:R12432